| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1721c0059eb480245ad4684968cc8785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd04957edb783a40d52f60d039670b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c49d726b48a5db46030e9d9344f938 |
| publicationDate |
2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03101199-A1 |
| titleOfInvention |
Combination therapy for rna virus infections involving ribavirin and impdh inhibitors |
| abstract |
This invention relates to the treatment of viral infections in animals, particularly mammals. The treatment comprises the administration of a pharmaceutical composition comprising combinations of antiviral compounds useful for treating viral infections. The anti-viral compounds are combined in such a manner as to reduce the detrimental side effects of treatment and to enhance the efficacy. In a particular embodiment, the invention provides a method for treating a viral infection in a mammal comprising administering to a mammal in need of such treatment a therapeutically effective amount of a combination of ribavirin in association with (S)-N-3-[3-(3-methoxy-4-oxazol-5-yl-phenyl)ureido]-benzylcarbamic acid tetrahydrofuran-3-yl-ester and pegylated interferon-alpha-2b. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383852-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809265-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192914-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969357-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017210262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1881828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101365678-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1881828-A4 |
| priorityDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |